Ensign Peak Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,197
Closed -$878K 1739
2024
Q4
$878K Hold
17,197
﹤0.01% 1398
2024
Q3
$709K Hold
17,197
﹤0.01% 1501
2024
Q2
$828K Buy
17,197
+100
+0.6% +$4.43K ﹤0.01% 1405
2024
Q1
$820K Sell
17,097
-863
-5% -$46.1K ﹤0.01% 1438
2023
Q4
$1.17M Buy
17,960
+2,800
+18% +$169K ﹤0.01% 1253
2023
Q3
$991K Hold
15,160
﹤0.01% 1210
2023
Q2
$881K Hold
15,160
﹤0.01% 1369
2023
Q1
$936K Buy
15,160
+300
+2% +$18K ﹤0.01% 1293
2022
Q4
$945K Buy
14,860
+6,200
+72% +$450K ﹤0.01% 1203
2022
Q3
$629K Buy
8,660
+6,300
+267% +$469K ﹤0.01% 1344
2022
Q2
$160K Hold
2,360
﹤0.01% 1862
2022
Q1
$214K Hold
2,360
﹤0.01% 1864
2021
Q4
$215K Buy
+2,360
New +$202K ﹤0.01% 1912

Other funds holding NARI

Ensign Peak Advisors's NARI Position: Q1 2025 in Review

Ensign Peak Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 17,197 shares — an estimated $878K sold.

Ensign Peak Advisors first reported a position in NARI in Q4 2021 and held it in 13 quarters. The position peaked at $1.17M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Ensign Peak Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 17,197 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $878K.
  • Ensign Peak Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • Ensign Peak Advisors's Inari Medical, Inc. Common Stock position peaked at $1.17M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.